AEGiS-GMHC: TREATMENT BRIEFS: Oral Ganciclovir Access Plan (Sort of) Gay Men's Health CrisisImportant note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.
Click here to return to Gay Men's Health Crisis main menu
DonateNow
Print this Article


TREATMENT BRIEFS: Oral Ganciclovir Access Plan (Sort of)

Gay Men's Health Crisis: Treatment Issues, Volume 8 no. 4 - June 1994
David Gold


The Syntex Corp. of Palo Alto, California has announced a program to make oral ganciclovir available to PWAs with CMV who are unable to receive ganciclovir through central catheter due to catheter infections or thrombosis (clotting of veins). Physicians should call 800/569-4630. Activists criticized the open label program because of the amount of time it took to develop and, more importantly, because it requires that patients must have a history of having a catheter removed two or more times due to catheter infection or thrombosis within the six months prior to enrollment. Kevin Frost of ACT UP and TAG called the program "laughable." Syntex plans to meet with community representatives to "discuss these issues."

Copyright (c) 1994 - GMHC Treatment Issues. Noncommercial reproduction encouraged. Distributed by AEGIS, your online gateway to a world of people, knowledge, and resources. Direct Dial: v.34+: 714.248.2836; v.120/ISDN: 714.248.0433 Internet: telnet:aegis.com www: www.aegis.com
9406
GM080413


Copyright © 1994 - Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011  fredg@gmhc.org  http://www.gmhc.org

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .